230
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Consumption of Tea and Risk for Pancreatic Cancer: A Meta-Analysis of Published Epidemiological Studies

, , , &
Pages 1109-1123 | Received 06 Jun 2013, Accepted 12 Jun 2013, Published online: 10 Sep 2014

REFERENCES

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer 127, 2893–2917, 2010.
  • Tanaka H: Advances in cancer epidemiology in Japan. Int J Cancer 134, 747–754, 2014. doi:10.1002/ijc.28519.
  • Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al.: SEER Cancer Statistics Review, 1975–2008. National Cancer Institute, Bethesda, MD, 2010–2011.
  • Kim SO and Kim MR: (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol, 42, 349–358, 2013.
  • DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7, 177–188, 1986.
  • Higgins JP, Thompson SG, Deeks JJ, and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327, 557–560, 2003.
  • Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101, 1994.
  • Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634, 1997.
  • Hara N, Sakata K, Nagai M, Fujita Y, Hashimoto T, et al.: Statistical analyses on the pattern of food consumption and digestive-tract cancers in Japan. Nutr Cancer 6, 220–228, 1984.
  • Wen-Qing Li, Shinichi Kuriyama, Qiang Li, Nagai M, Hozawa A, et al.: Citrus consumption and cancer incidence the Ohsaki cohort study. Int J Cancer 127, 1913–1922, 2010.
  • Kinlen LJ and McPherson K: Pancreas cancer and coffee and tea consumption: a case-control study. Br J Cancer 49, 93–96, 1984.
  • Mack TM, Yu MC, Hanisch R, and Henderson BE: Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76, 49–60, 1986.
  • Buenod HB, Mesquita DE, Maisonneuvec P, Moerman CJ, Runia S, et al.: Consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands Int J Cancer 50, 514–522, 1992.
  • Mizuno S, Watanabe S, Nakamura K, Omata M, Oguchi H, et al.: A multi-institute case-control study on the risk factors of developing pancreatic cancer. Jpn J Clin Oncol 22, 286–291, 1992.
  • Ji BT, Chow WH, Hsing AW, Mclaughlin JK, Dai Q, et al.: Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 70, 255–258, 1997.
  • Nagano J, Kono S, Preston DL, Mabuchi K: A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12, 501–508, 2001.
  • Michaud DS, Giovannucci E, Willett WC, Colditz GA, and Fuchs CS: Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10, 429–437, 2001.
  • Luo J, Inoue M, Iwasaki M, Shizuka S, Tetsuya O, et al.: Green tea and coffe intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16, 542–548, 2007.
  • Lin Y, Kikuchi S, Tamakoshi A, Kiyoko Y, Yuki O, et al.: Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 37, 25–30, 2008.
  • Nakamura K, Nagata C, Wada K, Tamai Y, Tsuji M, et al.: Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: A prospective cohort study in Japan. Japn J Clin Oncology 41, 225–231, 2011.
  • Turati F, Galeone C, Talamini R, Franceschi S, Manzari M, et al.: Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooled-analysis of two Italian case-control studies. Eur J Cancer Prev 20, 287–292, 2011.
  • Wang J, Zhang W, Sun L, Yu H, Ni QX, et al.: Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol 36, e354–e358, 2012.
  • Han C and Xu Y: The effect of Chinese teas on the occurrence of esophageal tumor induced by N-nitrosomethylbenzylamine in rats. Biomed Environ Sci 3, 35–42, 1990.
  • Yang CS and Wang ZY: Tea and cancer. J Natl Cancer Inst 85, 1038–1049, 1993.
  • Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, et al.: Influence of drinking green tea on breast cancer malignancy among Japanese patients. Japan J Cancer Res 89, 254–261, 1998.
  • Katiyar SK, Afaq F, Azizuddin K, and Mukhtar H: Inhibition of UVB-induced oxidative stress mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176, 110–117, 2001.
  • Conney AH, Lu Y, Lou Y, Xie J, Huang M: Inhibitory effect of green and black tea on tumor growth. Proc Soc Exp Biol Med 220, 229–233, 1999.
  • Qanungo S, Das M, Hal dar S, and Basu A: Epigallocatechi n-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosisi in pancreatic cancer cells. Carcinogenesis 26, 958–967, 2005.
  • Hofmann CS and Soneshein GE: Green tea polyphenolepi gallocatechin-3-gallate induces apoptosis of proliferating vasculars mooth muscle cells via activati on of p53. FASEB J 17, 702–704, 2003.
  • Nihal M, Ahmad N, Mukhtar H, and Wood GS: Anti-proliferative and proapoptotic effects of–epigallocatechin-3-gallateon human melanoma Possible implications for the chemoprevention of melanoma. Int J Cancer 11, 513–521, 2005.
  • Ahmad N, Gupta S, and Mukhrar H: Green tea polyphenol epigallocat echun-3-gallate differentially modulates nuclear factor Kappa-Bin cancer cells versus normal cell. Archives of Biochemistry and Biophysics 376, 338–346, 2000.
  • Vittal R, Selvanayagam ZE, Sun Y, Hong J, Liu F, et al.: Gene expression changes induced by green tea polyphenol-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Molecular Cancer Therapeutics 3, 1091–1099, 2004.
  • Liang YC, Lin-Shiau SY, Chen CF, and Lin JK: Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of CDK inhibitors p21 and p27 during growt harrest of human breast carcinoma cell by(-)-epigallocatechin-3-gallate. Journal of Cellular Biochemistry 75, 1–12, 1999.
  • Deguchi H, Fujii T, Nakagawa S, Koga T, and Shirouzu K: Analysis of cell growth inhibit or effects of catechin through MAPK in human breast cancer cell line T47D. International Journal of Oncol 21, 1301–1305, 2002.
  • Brusselmans K, Schrijver ED, Heyns W, Verhoeven G, and Swinnen JV. Epigallocatechin-3-gallateisapotent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. International Journal of Cancer 106, 856–862, 2003.
  • Ermakova S, Choi BY, Choi HS, Kang BS, Bode AM, et al.: The intermediate filament protein vimentin is a New target for epigallocatechin gallate. The Journal of Biology Chemistry 280, 16882–16890, 2005.
  • Balasubramanian S, Sturniolo MT, Dubyak GR, and Eckert RL: Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate-dependent differentiation but not apoptosis. Carcinogenesis 26, 1100–1108, 2005.
  • Okabe S, Ochiai Y, Aida M, Park K, Kim SJ, et al.: Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell Line. JPN J Cancer Research 90, 733–739, 1999.
  • McCarty MF: Polyphenol-mediated inhibition of AP-1 transactivating activity may show cancer growth by impeding angiogenesis and tumor invasiveness. Med Hypotheses 50, 511–514, 1998.
  • Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, et al.: Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev 21, 305–318, 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.